AR and posterior cortical atrophy: This distinction is biologically significant, as recurrence mechanisms in advanced PCa—shaped by treatment-induced microenvironmental changes (e.g., hypoxia, androgen receptor alterations)—differ fundamentally from postoperative recurrence driven by residual tumor burden.